Implant Veterans of Toxic Exposure

Study-Dogs-Silicone Migration

Congressional Report
AMT Audit
ASPRS Survey
Bell & Pointer
BI Capsules
BI Chemicals
BI Numbers - Dow
B-M's Spokesdoctors
Dr. Pierre Blais
Burson - NEW
Chemical Adverse
Chem Soup
Connie Chung
Dow Bleed
Dow Disease
Dow Fraud
Dow Migration
Dow Rupture
DC Whines
Dr. Anderson
Gel Reaction
Griffin Bell
Judge Jones Transcript
Maryland Informed
Poem to Congress
No Evidence
Norman Cole
Notable People
Study NY
Study-Tissue Reaction
Ultra Sound





Studies of the effects of injected dow corning 360 fluid cs


In dogs 


produced by dcc & dCw




Apr 11, 1968

Dow corning corporation

analytical dept.


Steven Carson, Ph. D.

Director-Biological Divisions

                                                                                                Maurice-Avenue at 58th Street

Submitted to   Dow Corning Corporation                              Maspeth, New York 11378               

                        Midland, Michigan


Date                February 28, 1968 

Laboratory No.816199B


Food and Drug Research Laboratories Incorporated





In an earlier report issued from these Laboratories   (No. 86199B dated December 15, 1967) the results of 2 year toxicologic studies in dogs receiving three injection regimens and one group on test for only one year were described.  The latter group consisted of three dogs that received one subcutaneous injection of 1 ml of C14 randomly labeled DC 360 fluid.  The test material was reported to be labeled in the end blocking methyl groups and in the methyl groups along the polymer chain.  The toxicological findings including tissue morphology at the end of a 1 year period were described.  The present supplement to the report covers the result of the C14 analyses of tissues from one dog sacrificed at each of three intervals up to one year.

The injection material, DC 360 Fluid cs, was described by Dow Corning Corporation as containing a specific activity of 1 mc per g.  Samples of injection fluid were received via Railway Express and bore the following labels

Date                                                       Label



6/4/65                                    Yellow label:  “Caution Radioactive material:  Isotope; Carbon 14       …Source  Strength: 5.0 mc..Serial Number: A-1494-131…Assay Date: 5-21-65..Investigator:  G. Vogel”

                                                White Label:  “Uniformly Carbon-14 labeled 360 Fluid…350 centistokes..1.0 mc/g..5.0 grams”

6/16/66                                  “Caution Radioactive Material;  Isotope:

                                                Carbon-14; Source strength: 0.50 mc;   Serial Number:  A-1640-41; Assay Date:  June 3, 1966; Investigator: G. Vogel”

                                                Shipping ticket identification:  “Dow Corning 360 fluid, 350 ca. cont’g. c-14, 1mc/g



Identification of the sample received on June 16, 1996 was inadvertently omitted from our report:  (Laboratory No. 86199B issued on December 15, 1967).



      The protocols employed are described in the report referred to above which included the findings with respect to the growth, food intake, hematological and clinical chemical findings as well as organ weights, gross and microscopic postmortem findings after sacrifice at 3,6, and 12 months.



      At autopsy, following selection of tissues for histological sectioning, the organs were prepared in separate labeled plastic bags and frozen liver, spleen, stomach, small and large intestines, pancreas, kidneys, urinary bladder, gonads, thyroid, thymus and salivary glands, lymph nodes, heart including aorta, lungs, skin, muscle, spinal cord, and brain.  They were stored and held in a frozen state until all samples were available after completion of the 1-year sacrifice.  They were shipped in the frozen state to our collaborating laboratory (New England Nuclear Corporation) for radioactive counting.  Portions of the tissues were weighed in sealed tubes, combusted, diluted with priming fluid, and counted in a scintillation counter.


      The distribution of animals, their body weights and time of initiation are shown below:



        Animal No.           Body Weight                        Total Dose            Time of Sacrifice


                                                        kg                            ml           mc                          months

        9913M                                   6.2                          1              1                                  3

        9914M                                   8.3                          1              1                                  6

        9915M                                   8.9                          1              1                               12

                Inasmuch as the experiment was not designed as a balance study, organ weights were recorded only for the eight major organs of the dogs.




                The appended tables include the individual radioactive counts together with organ weights and total activity on an organ basis of the liver, spleen, kidneys, gonads, thyroid, heart, lungs and brain.


            The date are summarized for the 3-, 6-, and 12 month intervals in Tables 1, 2 and 3, respectively, and in each instance the specific C14 activity is shown for the individual organs.  The data are indicative of an ubiquitous distribution among all the organs and tissues without evidence of tissue concentration.  Although the total counts in several of the larger organs may be somewhat elevated (e.g., in the liver and brain at 3 months, liver, spleen, heart, lungs, and brain at 6 months, and the liver and kidneys at 12 months), they are not indicative of selective concentration based on specific activity counts but rather a function of organ weight.  The broad distribution can be followed by an examination of the patterns in the organs of excretion, i.e., the kidneys and bladder, in which significant activity may be noted.  This was most marked at 6  months, the gladder and kidney counts approaching the nanocurie level.


            It is of interest that despite parenteral route of administration, C14 was present in the gastrointestinal tract, in the aorta and apparently in the lymphatic pathways as evidenced by the lymph nodes, and salivary glands, thus suggesting that transport and distribution in these animals was via the vascular system, the lymphatics, and recirculation via the biliary tract.


Summary and Conclusions

Counts for radioactivity of tissue samples taken from dogs 3, 6, and 12 months, respectively, after a single subcutaneous dose of C14 – labeled DC 360 Fluid, 350 cs provides indication of generalized distribution throughout all the organs and tissues.  Transport via the vascular network (i.e., the lymphatics) and biliary recirculation is suggested by the presence of  C14 in these organs and suggests that the material was being excreted via normal pathways in the urinary and gastrointestinal tracts.  The generalized distribution is without pattern of tissue concentration and is further indication of its broad, non-specific distribution at low levels of concentration.


            The results of radioactive studies following parenteral administration  of a single 1 cc dose of DC 360 Fluid suggests that distribution occurs throughout the entire body with no apparent concentration in any specific organ.  Examination of organs at 3, 6, and 12 month intervals warrants the conclusion that the material is mobilized from the injection site as evidenced by the decreased volume of the injection site by palpation and is excreted via normal urinary and gastrointestinal pathways.  The latter observation is indicative of biliary recirculation since the material was not administered orally.


      The ubiquitous distribution throughout the organism indicates that the material or its metabolic products are mobilized from the injection site and are handled via normal excretory patterns.  Because this was not designed as a balance study initially, conclusions as to rate of mobilization and clearance are unwarranted.  These findings are confirmatory of the passive role played by the parenterally administered materials as tentatively concluded in the report of the 2 year study.


            Although there are quantitive differences in distribution between the findings at 6 months and at the 3 and 12 months, there is no explanation for these.  In view of the limited numbers of animals (1 per time interval), and their qualitative similarity, indicative of lack of specific organ concentration, the variation between the 3 and 6  month counts is believed to be essentially the same at each of the periods and is illustrative of a continuous slow process.


Enter supporting content here

Site maintained by Pamela G. Dowd